Changes in Hong Kong stocks | Path to Health (02587) rose more than 20% intraday, strategic reallocation of IPO capital to increase commercialization path of AI smart devices is clear and verifiable

The Zhitong Finance App learned that the Path to Health (02587) rose significantly this morning, with an intraday high of more than 20%, hitting a high of HK$2.56. As of press release, it rose 8.45% to HK$2.31, with a turnover of HK$150 million.

According to the news, at the end of last month, Health Path issued a supplementary announcement to strategically reallocate approximately HK$107 million of unused IPO capital. Among them, the original plan was to expand physical pharmacies, recruit on-site health assistants and business representatives on a large scale, and fully shift to AI smart technology research and development and regional ecological layout. It is worth noting that adding AI this time is not conceptual hype; the company's related business has been implemented continuously, and the commercialization path is clear and verifiable.

In 2025, AI agents generated more than 32 million yuan in revenue in the first year of their launch. In March of this year, the company joined the Sichuan Orthopedic Hospital and Anji County People's Hospital digital intelligence project; in June, it won the bid for the Rizhao mobile computing power grid project. On July 20, Health Path and Xi'an Health Medical Group signed an AI smart community co-construction agreement, which plans to cover the first batch of 30 primary medical institutions in Xi'an. This indicates that the company's AI solution has moved from a single-site pilot to standardized batch delivery.